-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Sutro Biopharma, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2018 to Q1 2024.
- Sutro Biopharma, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $1.76M, a 9.04% increase year-over-year.
- Sutro Biopharma, Inc. annual Depreciation, Depletion and Amortization for 2023 was $6.82M, a 19.8% increase from 2022.
- Sutro Biopharma, Inc. annual Depreciation, Depletion and Amortization for 2022 was $5.69M, a 17.5% increase from 2021.
- Sutro Biopharma, Inc. annual Depreciation, Depletion and Amortization for 2021 was $4.84M, a 12.7% increase from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)